Page last updated: 2024-12-07

4-phosphonomethylphenylalanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-(phosphonomethyl)-L-phenylalanine : A 4-(phosphonomethyl)phenylalanine that has L-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

4-(phosphonomethyl)phenylalanine : A phenylalanine derivative that is phenylalanine substituted by a phosphonomethyl group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID126687
SCHEMBL ID738555
MeSH IDM0223263

Synonyms (31)

Synonym
4-(phosphonomethyl)phenylalanine
2-amino-3-(4-phosphonomethyl-phenyl)-propionic acid
4-phosphonomethylphenylalanine
(2s)-2-amino-3-[4-(phosphonomethyl)phenyl]propanoic acid
142434-81-9
4-phosphonomethyl-l-phe
p-(phosphonomethyl)phenylalanine
l-phenylalanine, 4-(phosphonomethyl)-
4-phosphonomethyl-l-phenylalanine
114791-27-4
SCHEMBL738555
AM83477
4-phosphonomethyl-l-phenylalanine (h-l-phe(4-ch2po3h2)-oh)
mfcd03701454
AKOS027383595
J-007649
4-phosphomethyl-l-phenylalanine
4-phosphonomethyl-phenylalanine
4-(phosphonomethyl)-l-phenylalanine
142434-80-8
Q27464477
DTXSID20931448
AC1165
(s)-2-amino-3-[4-(phosphonomethyl)phenyl]propanoic acid
(s)-2-amino-3-(4-(phosphonomethyl)phenyl)propanoic acid
A920917
(s)-2-amino-3-(4-(phosphonomethyl)phenyl)propanoicacid
l-pmp-oh
2-amino-3-[4-(phosphonomethyl)phenyl] propanoic acid
l-4-(phosphonomethyl)-phe-oh
d-4-(phosphonomethyl)-phe-oh
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's3 (37.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.02 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]